跳转至内容
Merck
CN

377627

2-亚氨基-1-咪唑啉乙酸

98%

别名:

1-羧甲基-2-亚氨基咪唑烷, 环肌酸

登录 查看组织和合同定价。

选择尺寸

变更视图

关于此项目

经验公式(希尔记法):
C5H9N3O2
化学文摘社编号:
分子量:
143.14
NACRES:
NA.22
PubChem Substance ID:
UNSPSC Code:
12352100
MDL number:
Assay:
98%
Form:
solid
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助


Quality Level

assay

98%

form

solid

solubility

1 M HCl: soluble 25 mg/mL, clear, colorless

functional group

carboxylic acid

SMILES string

OC(=O)CN1CCNC1=N

InChI

1S/C5H9N3O2/c6-5-7-1-2-8(5)3-4(9)10/h1-3H2,(H2,6,7)(H,9,10)

InChI key

AMHZIUVRYRVYBA-UHFFFAOYSA-N

General description

2-亚氨基-1-咪唑烷乙酸(环肌酸)是肌酸的一种类似物。据报道,它在某些移植的人或啮齿类肿瘤体内展现出了抗肿瘤的效果。 它被报道为肌酸激酶的一种有效底物。 它是一种抗癌和神经保护剂。通过X射线衍射方法研究了环肌酸的晶体结构。据报道,它在单斜晶系中结晶为两性离子。

Application

2-亚氨基-1-咪唑烷乙酸(环肌酸)适用于研究环肌酸对裸鼠皮下移植的LS174T人结肠腺癌的生长抑制作用。 它可用于评估脑型肌酸激酶(CKB)在香烟烟雾诱导的支气管上皮细胞衰老中的作用。
心脏线粒体呼吸作用免受甲基乙二醛抑制的保护剂

霍奇金病衍生细胞系的生长抑制

在大鼠肝癌发生模型中作用的研究

Biochem/physiol Actions

可以保护组织免受缺血性损伤的肌酸类似物;通过肌酸激酶可以降低 ATP 的合成率,还可抑制肿瘤细胞系的增殖,特征就是高水平的肌酸激酶表达。


pictograms

Exclamation mark

signalword

Warning

Hazard Classifications

Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3

target_organs

Respiratory system

存储类别

11 - Combustible Solids

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

ppe

dust mask type N95 (US), Eyeshields, Gloves



历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

没有发现合适的版本?

如果您需要特殊版本,可通过批号或批次号查找具体证书。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库



B A Teicher et al.
Cancer chemotherapy and pharmacology, 35(5), 411-416 (1995-01-01)
Cyclocreatine, an analog of creatine, is an efficient substrate for creatine kinase, but its phosphorylated form is a poor phosphate donor in comparison with creatine phosphate. Cyclocreatine was not very cytotoxic upon 24 h of exposure of human SW2 small-cell
Vijay Pralhad Kale et al.
Regulatory toxicology and pharmacology : RTP, 117, 104750-104750 (2020-08-04)
Cyclocreatine (LUM-001), a creatine analog, was evaluated for its nonclinical toxicity in Sprague Dawley (SD) rats. Deionized water as a vehicle control article or cyclocreatine was administered by oral gavage twice daily (approximately 12 ± 1 h apart) at 30, 100 and 300 mg/kg/dose
R T Matthews et al.
The Journal of neuroscience : the official journal of the Society for Neuroscience, 18(1), 156-163 (1998-01-24)
The gene defect in Huntington's disease (HD) may result in an impairment of energy metabolism. Malonate and 3-nitropropionic acid (3-NP) are inhibitors of succinate dehydrogenase that produce energy depletion and lesions that closely resemble those of HD. Oral supplementation with



全球贸易项目编号

货号GTIN
377627-1G04061831835700